DUBLIN--(BUSINESS WIRE)--The "The Era of Uncertainty in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging - 27 Factors That Could Disrupt the Market" report has been added to ResearchAndMarkets.com's offering.
In healthcare, there are 27 potential disruptors that could have a large impact on the market:
- New US Healthcare Policies/ACA Status
- Reimbursement Changes in Europe and Other Developed Nations
- Emerging Countries
- Demographic Changes
- Ransomware and Blockchain Strategies
- Walk-in Clinics
- Empowered Consumers
- "Gig" Economy
- Value-Based Reimbursement
- Brazilian Biotech Market
- Healthcare in China
- Association Healthcare Plans
- Brazil as a Significant Pharma Player
- Technology Advances
- Physician Shortages, Advanced Nurse Surplus
- Changes in Drug Sourcing
- Mergers and Acquisitions
- IPO and Venture Investment
- Plus Others
This report details current challenges and upending factors in healthcare markets globally. It also processes these developments into useful market forecasts in overall healthcare and pharmaceuticals specifically, in 18 ten-year forecast tables.
Empowered Healthcare Consumers: The Internet has dramatically increased the availability of medical, health and wellness information for consumers in virtually all world markets. As of early 2018, almost 4 billion people used the Internet, representing over 52% of the world's population. Usage is highest in North America and Europe, with about 90% and 80% of the population online, respectively. While just 32% of Africa is online and about 48% of Asia, these proportions are expected to increase strongly over the next several years.
As a result, consumers are easily able to access:
- Health and wellness information in online publications, platforms and communities;
- Provider (physician, hospital, lab, insurance) websites and information.
As a result, patients are becoming better educated and informed. By learning about the availability of healthcare products and services in other areas and connecting with other providers, they are also increasing competition in the marketplace.
MACRA and Value Based Reimbursement - also known as Quality-Based Reimbursement, VBR is a means to compensate care providers in a way that ties payments to the quality of care provided while rewarding providers for efficiency and effectiveness. It is an alternative to fee-for-service (FFS) reimbursement which pays providers for services delivered based on bill charges or annual fee schedules.
This unique report takes a look at these factors and how they could impact pharmaceutical and healthcare markets.
The report includes the following forecasts:
- Global Healthcare Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
- U.S. Healthcare Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
- Europe Healthcare Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
- Global Pharmaceutical Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
- U.S. Pharmaceutical Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
- Europe Pharmaceutical Market, 2017-2027 - Worst Case/Best Case/Most Like Case Scenario
Key Topics Covered
1. Executive Summary
3. Key Issues: U.S.
4. Key Issues: Europe
5. Key Issues: Emerging Markets
6. Considering the 27 Factors - Best/Worst/Moderate Case Market Forecasts
For more information about this report visit https://www.researchandmarkets.com/research/3jp8lg/the_era_of?w=4